baber/WOPTO huggingface dataset:
Patent DK-0610601-T3 (DK)
Inventor: GARBASSI FABIO
IPC: C08G67/00
Filed: 1993-02-06
Granted: 1998-03-16
Abstract: Process for preparing straight, alternate polymers based on carbon monoxide and at least one olefin, which comprises causing carbon monoxide and the olefin to react in the presence of:     (a) a catalyst of general formula (I):    [Pd(chel)(chel')]<+><+>[A<->]2   (I> wherein chel and chel', which may be the same, or different from each other, represent a bidentate chelating agent and A<-> stands for an anion of an acid having a pKa smaller than 6; and (b) optionally, an organic oxidizer agent.
Patent DK-0619837-T3 (DK)
Inventor: ROTH STEPHEN
IPC: C12P19/18
Filed: 1992-12-21
Granted: 2001-12-03
Abstract: A reiterative method for obtaining the glycosyltransferases useful for glycosyltransferase-catalyzed synthesis of a saccharide composition by serially bonding preselected saccharide units onto an immobilized acceptor moiety which is one member selected from the group consisting of proteins, glycoproteins, lipids, glycolipids and carbohydrates. The method comprises in a first iteration, the steps of (i) contacting an acceptor moiety immobilized onto a solid or semi-solid support with a mixture containing at least one glycosyltransferase under conditions effective to allow said glycosyltransferase to bind to the immobilized acceptor moiety thereby resulting in an immobilized acceptor moiety-glycosyltransferase complex, followed by (ii) contacting the immobilized acceptor moiety-glycosyltransferase complex with a preselected saccharide under conditions and in the presence of co-reagents sufficient to effect bonding of the preselected saccharide unit onto the immobilized acceptor moiety catalyzed by the glycosyltransferase thereby freeing the glycosyltransferase from the complex and obtaining an immobilized product. This is followed by a single or a plurality of subsequent iterations of steps (i) and (ii), such that the immobilized product obtained in step (ii) of a given iteration is used as the immobilized acceptor moiety in step (i) of the following iteration.
Patent DK-0647076-T3 (DK)
Inventor: REMY JEAN-GABRIEL
IPC: H04W4/029
Filed: 1994-10-03
Granted: 2004-05-17
Abstract: The invention relates to a cellular radio communication system employed within a network of geographical cells traversed by mobile stations, the said system comprising means (11) for supplying a mobile station with at least one personalised service on the basis of information on the geographical location of the said mobile station. According to the invention, the system comprises:   - means (23) for recognising and branching off a first signalling message (22) transmitted between a base station subsystem and a switching and network subsystem; - means (26) for picking off the location information contained in the first branched-off signalling message, and - means of routing the said location information picked off towards the said means (11) for supplying at least one personalised service related to the location.   <IMAGE>
Patent DK-0626983-T3 (DK)
Inventor: JONES STEPHEN ALISTER
IPC: C08L101/00
Filed: 1993-12-23
Granted: 1999-10-25
Abstract: Disclosed is a polymer blend composition and shaped article, and a process of blending and making shaped articles of polymer blends in which the biocompatibility of various polymers is improved by blending with them a polymer including a zwitterionic group. The zwitterionic group is usually an ammonium phosphate ester, preferably a choline, zwitterionic group and the polymer containing it may be produced by the free radical polymerization of ethylenically unsaturated monomers including a monomer bearing the zwitterionic group. Blending of the two polymers may be achieved by dry blending particulate polymers or by mixing the polymers in liquid dispersion or solution followed by removal of the liquid medium. The fibrinogen absorption and/or platelet activation of polymers may be reduced to a value of less than 80% or even less than 60% of the base polymer by introducing amounts of more than 10% or more than 30% of the zwitterionic group containing polymer.
Patent DK-0697058-T3 (DK)
Inventor: STEWART ARTHUR DEACEY
IPC: E21B17/10
Filed: 1994-05-09
Granted: 1997-08-18
Abstract: PCT No. PCT/GB94/01001 Sec. 371 Date Nov. 14, 1995 Sec. 102(e) Date Nov. 14, 1995 PCT Filed May 9, 1994 PCT Pub. No. WO94/27024 PCT Pub. Date Nov. 24, 1994A drill pipe (10) having first and second end portions (12, 14) at opposite longitudinal ends thereof and a middle portion (16) extending between said first and second end portions; said end portions having a first outside diameter and said middle portion having a second outside diameter less than said first outside diameter; and said drill pipe having a plurality of centraliser means (22, 24, 26) spaced along the length of said middle portion. The centralisers have an outside diameter greater than the outside diameter of the middle portion and, preferably, equal to or greater than the outside diameter of the end portions. The centralisers may be formed integrally with the drill pipe and arc preferably arcuate in longitudinal cross section and formed with hard-faced spiral flutes.
Patent DK-0749460-T3 (DK)
Inventor: NARAYAN RAMANI
IPC: C08L67/04
Filed: 1995-03-06
Granted: 2002-09-16
Abstract: Compatibilized blends of a biodegradable hydrophobic polyester, unmodified starch or other similar polysaccharide containing less than 1% water by weight, other biodegradable polymers that may be hydrophobic, plasticizer, and other additives. The blends are produced in the absence of water. The preferred polyester polymer is poly( epsilon -caprolactone) and the preferred starch is from corn. A small amount of a unique stretching agent is incorporated to provide high elongations at break, especially in film forming compositions containing a significant amount of starch. The starch is a discontinuous phase that may be completely or partially plasticized and the polyester polymer is the continuous phase. The preferred polymers have unique film forming properties and are resistant to water and moisture.
Patent DK-0778747-T3 (DK)
Inventor: BAEKGAARD KNUD ERIK
IPC: A61B7/04
Filed: 1995-08-30
Granted: 2006-07-31
Abstract: PCT No. PCT/DK95/00349 Sec. 371 Date Feb. 28, 1997 Sec. 102(e) Date Feb. 28, 1997 PCT Filed Aug. 30, 1995 PCT Pub. No. WO96/06562 PCT Pub. Date Mar. 7, 1996An electronic stethoscope consisting of a transducer, an amplifier and a headphone will be better adapted to the habits of use of doctors when it is supplied with filters which mimic the transfer function of acoustic stethoscopes. Thus, the signals heard will correspond to those learnt, and thereby the advantages of greater amplification and elimination of noise sources may be fully utilized. Hence there is a possibility for extended digital signal processing which may furthermore compensate for the hearing loss of each individual doctor.
Patent DK-0824539-T3 (DK)
Inventor: MCALPINE JAMES B
IPC: C07H17/08
Filed: 1996-05-02
Granted: 2001-09-24
Abstract: Antimicrobial compounds having the formula   <IMAGE>   as well as pharmaceutical compositions comprising such compounds and methods of treating bacterial infection and colitis by the administration thereof.
Patent DK-0845125-T3 (DK)
Inventor: EGENDORF ANDREW
IPC: G06Q30/00
Filed: 1996-06-06
Granted: 2003-07-28
Abstract: An Internet billing method comprises establishing an agreement between an Internet access provider and a customer, and an agreement between the Internet access provider and a vendor, wherein the Internet access provider agrees with the customer and the vendor to bill the customer and remit to the vendor for products and services purchased over the Internet by the customer from the vendor. The provider creates access to the Internet for the customer. When the customer orders a product or service over the Internet from a vendor, transactional information transmitted between the customer and the vendor is also transmitted to the provider. The provider then bills the transaction amount to the customer and remits a portion of the transaction amount to the vendor, keeping the differential as a fee for providing the service. As a result of this method, there is no need for any customer account numbers or vendor account numbers to be transmitted over the Internet, thereby maintaining the security of that information.
Patent DK-0830601-T3 (DK)
Inventor: MATHIS GERARD
IPC: C07K16/18
Filed: 1996-06-07
Granted: 2000-04-10
Abstract: PCT No. PCT/FR96/00865 Sec. 371 Date Feb. 23, 1998 Sec. 102(e) Date Feb. 23, 1998 PCT Filed Jun. 7, 1996 PCT Pub. No. WO96/42016 PCT Pub. Date Dec. 27, 1996The use of a phycobiliprotein-linker peptide complex as a fluorescent tracer in a fluorescent method of detecting and/or determining an analyte in a medium in which it may be present, is disclosed. Fluorescent conjugates consisting of said complex covalently bonded to one of the elements of a ligand/receptor specific binding pair, are also disclosed.
Patent DK-0801144-T3 (DK)
Inventor: FLEISCHER WERNER DR-ING
IPC: C23C16/02
Filed: 1997-03-07
Granted: 2001-08-06
Abstract: A component or tool has a wear protection layer (2) which includes a mixed layer (5) formed of a hard material component and an unipolar material component with non-stick properties wrt. plastics. Preferably, the hard material component consists of TiN, TiCN, CrN, CrCN, ZrN and/or TiAlN and the unipolar material component consists of MoS2. Also claimed is a method of producing the above component, in which the wear protection layer (2) is vacuum deposited by PVD, CVD or a combination of these processes, the components preferably being applied by means of separate sources, especially arc, sputter, electron beam or thermal evaporation sources.
Patent DK-0851079-T3 (DK)
Inventor: STEFANESCU ALEXANDER
IPC: E05B19/00
Filed: 1997-06-26
Granted: 2004-04-26
Abstract: A locking cylinder (1) with a cylindrical housing (2) of which the core bore (7) receives a cylindrical core (8) having a key channel (9) with core pins provided in the cylindrical core and housing pins displaceably guided in housing pin bores, the housing pins being resiliently biased by springs in the direction of the core pins, and with at least one additional, core-adjacent tumbler element (15) adjacent the wide-side profile of the key, the element (15) being displaceable in a cavity (H) crossing the rotational interface of the cylindrical core, the tumbler element being spring biased in the outward direction of the core and having a control projection (22, 51) projecting sidewards into the key channel (9, 43). In order to provide greater security, a locking recess (13', 48) is located in crossing or opposing relation to the housing pin bores, for receiving the additional tumbler element (15, 49) so as to block rotation, in which a housing-adjacent tumbler pin (14) biased in the inward direction of the core is able to project into the core cavity (13) when the tumbler pin (15) is withdrawn across the rotational interface (F), and in which the spring force of the spring (17) loading the additional tumbler element (15) is larger than that of the spring (18) which loads the housing-adjacent tumbler element (14).
Patent DK-0951349-T3 (DK)
Inventor: RIERA MICHEL
IPC: F02M27/04
Filed: 1997-08-13
Granted: 2003-02-17
Abstract: A device for generating a magnetic field moving in at least one field plane located in a fluid to be treated and in which the gradient of the vector product between the intensity of the magnetic field and its displacement velocity induces stereochemical deformations of the molecules of the treated fluid, which may be a limestone water or a fuel. Each field plane may have a first magnetic field generator such as a pair of coils ( 10, 10' ) and a second magnetic field generator such as a pair of coils ( 12, 12' ) forming an angle theta with the first generator, both being disposed at the periphery of the pipe ( 20 ) through which the fluid to be treated is flowing. At least one of the two field generators generates a magnetic field whose amplitude is variable over time so that the resultant is a magnetic field moving in the field plane having a variable amplitude and a direction moving at an angular velocity such as to obtain the highest possible gradient of the vector product.
Patent DK-0926137-T3 (DK)
Inventor: HIRAI HIDEO
IPC: C07D401/04
Filed: 1998-10-29
Granted: 2004-08-09
Abstract: The present invention provides novel 5-substituted picolinic acid compounds of formula (I) or a pharmaceutically acceptable salt thereof: <CHEM> wherein R<1> and R<2> are independently H, C2-C6 acyl or halo-substituted benzoyl; and R<3> is -C(O)O-C1-C6 alkyl, C(O)OH, CN, CONH2, CONHCH3, CON(CH3)2, 1-methyltetrazole or 2-methyltetrazole, with the proviso that when R2 is acetyl and R<3> is methoxycarbonyl, R<1> is not H; and that when R<3> is CN, CONH2, CONHCH3, CON(CH3)2, 1-methyltetrazole or 2-methyltetrazole, R<1> and R<2> are H. The present invention also relates to a pharmaceutical composition comprising compound of the present invention, which is useful in the treatment of IL-1 and TNF mediated diseases or the like. The present invention further relates to a process for producing the compounds of the formula (I).
Patent DK-0966532-T3 (DK)
Inventor: PIECHACZYK MARC
IPC: A61K48/00
Filed: 1998-01-16
Granted: 2007-07-30
Abstract: The invention concerns a biological material for preparing a pharmaceutical compositions for treating a mammal by gene transfer, comprising, either at least a nucleic acid sequence containing a therapeutic gene and in a form enabling in vivo transfer of said gene into the cells of the mammal, or at least one cell of the mammal not naturally producing antibodies, genetically modified in vitro by at least a previous nucleic acid sequence, and in a form enabling its incorporation into the mammal's system as well as optionally its previous culture. The invention is characterised in that said nucleic acid sequence contains an antibody gene and elements for expressing in vivo said antibody gene and the secretion in the blood circulation of a mammal a therapeutically effective amount of this antibody or a fragment of it, by cells of said mammal genetically modified by said nucleic acid sequence and not naturally producing antibodies. The invention also concerns the pharmaceutical compositions containing this biological material.
Patent DK-0967862-T3 (DK)
Inventor: PHIPPS DIANA JOHANNA
IPC: A01N1/02
Filed: 1998-02-06
Granted: 2003-05-12
Abstract: The invention provides methods for drying platelets to obtain compositions which are storage stable over a wide range of temperatures and for an extended period of time. The invention also provides compositions obtained thereby and devices for use therein.
Patent DK-0966519-T3 (DK)
Inventor: HENNEN UDO
IPC: C11D3/12
Filed: 1998-02-21
Granted: 2001-10-15
Abstract: A molded synthetic composition is presented having at least 25% by weight synthetic surfactants, at least 30% by weight non-surface-active organic plasticizers and fillers, and 5 to 30% by weight of talcum. The composition provides improved moldability and initial foam quality.
Patent DK-0981540-T3 (DK)
Inventor: MANKER DENISE CAROL
IPC: A01N63/50
Filed: 1998-05-08
Granted: 2006-11-06
Abstract: The present invention relates to a novel antibiotic-producing and metabolite-producing Bacillus subtilis strain that exhibits insecticidal, antifungal and antibacterial activity. The supernatant of this novel strain contains effective insecticidal, antifungal and antibacterial agents. Also included in the invention is a solvent extractable, small molecular weight (<10,000 daltons) corn rootworm-active metabolite produced in the supernatant. Also included in the invention are methods of protecting or treating plants from fungal and bacterial infections and corn rootworm infestations comprising the step of applying to the plant an effective amount of the antibiotic/metabolite-producing novel Bacillus subtilis strain, the antibiotic/metabolite produced by the novel Bacillus subtilis strain or a combination thereof, optionally further comprising another antibiotic-producing bacterial strain and/or a chemical pesticide. The invention also includes methods of preventing or treating fungal and bacterial infections using whole broth cultures or supernatants obtained from cultures of the novel Bacillus subtilis strain alone or in combination with chemical pesticides and/or other biocontrol agents. The invention also includes novel antifungal and antibacterial compounds designated agrastatins and a novel combination comprising an A-type iturin, a plipastatin, a surfactin and an agrastatin. Methods of treating or protecting plants from fungal and bacterial infections and corn rootworm infestations comprising administering the novel agrastatins and the novel combination comprising an A-type iturin, a plipastatin, a surfactin and an agrastatin are provided.
Patent DK-0969877-T3 (DK)
Inventor: SCHAPER WOLFGANG
IPC: A61K38/00
Filed: 1998-04-01
Granted: 2003-03-24
Abstract: Described is the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections. Methods are provided for enhancing the growth of collateral arteries and/or other arteries from preexisting arteriolar connections comprising contacting tissue or cells with a monocyte chemotactic protein (MCP) or a nucleic acid molecule encoding said MCP. Furthermore, the use of a MCP or a nucleic acid molecule encoding said MCP for the preparation of pharmaceutical compositions for enhancing collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections is described. Also provided are methods for the treatment of tumors comprising contacting tissue or cells with an agent which suppresses the growth of collateral arteries and/or other arteries from preexisting arteriolar connections through the attraction of monocytes. Also described is the use of an agent which suppresses the growth of collateral arteries and/or other arteries from preexisting arteriolar connections through attraction of monocytes for the preparation of pharmaceutical compositions for the treatment of tumors.
Patent DK-1003525-T3 (DK)
Inventor: PHILLIPS NIGEL C
IPC: A01N63/00
Filed: 1998-08-05
Granted: 2003-03-24
Abstract: A composition (A) for inducing a response in the cell of an animal comprises: (a) a mycobacterial DNA (B-DNA); and (b) a first carrier. - Independent claims are also included for: (1) a method (AA) for using the composition (A) to induce a response in the cell of an animal; (2) a method (BB) for inducing a caspase activity in cells of an animal, by administering a composition (B) comprising: (a) a mycobacterial composition M-DNA, and (b) a first carrier which is Mycobacterium phlei cell wall; and (3) composition (B).
Patent DK-0947551-T3 (DK)
Inventor: HESSE ACHIM DR
IPC: C08J5/18
Filed: 1999-03-25
Granted: 2004-06-21
Abstract: Polyolefin films or coatings on substrates, e.g. textiles, plastics, films, paper, cardboard or metal comprise modified polypropylenes and unmodified polypropylenes, including stabilizers, processing aids and pigments. Polyolefin films or polyolefin coatings on substrates, e.g. textiles, plastics films, paper, cardboard or metal, comprise: (a) up to 100 (preferably 5-50) wt.% modified polypropylenes with a melt flow index of 0.1-50 (preferably 1-40) g/10 minutes at 230 degrees C and 2.16 kg, where the ratio of the limiting viscosity of the modified polypropylene to that of an unmodified polypropylene with approximately the same molecular weight is 0.2-0.95; and (b) preferably 50-95 wt.% of unmodified polypropylenes selected from (i) propylene homopolymers and/or copolymers (statistical and/or block copolymers) with ethylene and/or 4-18C  alpha -olefins, with a propylene content of 80-99.9 wt.%, preferably produced using Ziegler-Natta or metallocene catalysts, with a melt flow index of 0.1-300 (preferably 1-150) g/10 minutes at 230 degrees C and 2.16 kg; and/or (ii) polyolefin mixtures with a Mn/Mw ratio of 2-6 and a melt flow index of 1-40 g/10 minutes at 230 degrees C and 2.16 kg, comprising 60-98 wt.% of a crystalline copolymer of 85-99.5 wt.% propylene and 0.5-15 wt.% ethylene or 4-10C  alpha -olefin and 2-40 wt.% of an elastic copolymer of 20-70 wt.% ethylene and 30-80 wt.% propylene and/or 4-10C  alpha -olefin; and/or (iii) amorphous propylene (co)polymers that contain less than 10 wt.% crystalline phase, have an enthalpy of melting below 40 J/g, have a melt flow index of 0.1-100 g/10 minutes at 230 degrees C and 2.16 kg and comprise at least 80 mol% propylene and no more than 20 mol% 4-10C  alpha -olefin; and/or (iv) non-isotactic polypropylene having a melting point of 145-165 degrees C, a melt viscosity of more than 200,000 cP at 190 degrees C, a heat of crystallization of 4-10 cal/g and an ether soluble content of 35-55 wt.%. The polypropylenes also contain 0.01-2.5 wt.% stabilizers, 0.01-1 wt.% processing aids and optionally 0.1-1 wt.% antistatic, 0.2-3 wt.% pigments, 2-20 wt.% flame retardants and/or 0.05-1 wt.% nucleating agents and/or 10-70 (preferably 20-50) wt.% (in)organic fillers and/or reinforcers. The modified polypropylenes are produced by (1) treating propylene homopolymers and/or copolymers with ethylene or 4-18C  alpha -olefins with polyfunctional ethylenically unsaturated monomers in the presence of ionizing radiation or thermally decomposable radical sources, or (2) reacting functionalized polypropylenes, preferably containing acid and/or anhydride groups, with polyfunctional compounds of opposite reactivity, preferably 2-16C diamines and/or 2-16C diols, or (3) hydrolytic condensation of polypropylenes containing hydrolyzable silane groups.
Patent DK-1079836-T3 (DK)
Inventor: CARRUTHERS MALCOLM E
IPC: A61K31/565
Filed: 1999-03-29
Granted: 2004-02-16
Abstract: Treatment of androgen deficiency using a pharmaceutically effective dose of ethisterone or an ethisterone derivative such as danazol. In particular, androgen deficiency in the aging male, also known as the male climateric andropause or the male menopause, can be treated by ethisterone or ethisterone derivatives. Treatment of hypogonadism using ethisterone or ethisterone derivative in combination with testosterone is also effective.
Patent DK-1104297-T3 (DK)
Inventor: NARDELLA FRANCIS A
IPC: A61K31/407
Filed: 1999-07-08
Granted: 2006-05-29
Abstract: The level of the leukemic lymphocytes in patients suffering from chronic lymphocytic leukemia (CLL) is reduced by the administration of certain indole or carbazole compounds, such as the nonsteroidal anti-inflammatory drug etodolac or related indole or carbazol compounds.
Patent DK-1228937-T3 (DK)
Inventor: IPARRAGUIRRE AGUIRRE RAFAEL
IPC: B61F5/38
Filed: 1999-08-31
Granted: 2005-01-24
Abstract: The invention relates to a device for guiding the axles of a rail vehicle having at least one articulation-actuator mounted between two elements of the bogie of said vehicle that are movable relative to one another, said articulation-actuator comprising: an outer casing (1) connected to one of the mobile elements; an inner axle (2) connected to the axle of the mobile elements; an elastomer assembly (3) connecting the outer case (1) to the inner axle (2); two sealed chambers, one inner (6) and one outer (5) chamber, which are located between the outer casing (1) and the inner axle (2) and which are filled with fluid, the inner chamber (6) being located on the side of the mobile elements and the outer chamber (5) being located on the side of the other mobile element; two conduits (7) communicating said chambers (5) (6) with an outer fluid distributing device. The invention can be used in railroad vehicles.
Patent DK-1113964-T3 (DK)
Inventor: MOONS WILHELMUS ANDREAS MARIA
IPC: B29C53/26
Filed: 1999-09-07
Granted: 2003-07-21
Abstract: The invention relates to a device for the automatic packaging of foodstuffs which have been cut into slices, and in particular relates to making the support for receiving cut slices and collecting them into a group. According to the invention, the support is made from an endless sheet which is wound on a reel, and the device comprises deformation means and cutting means.